Abstract
The optimal type and duration of antifungal therapy for localized aspergillosis in cardiac transplant recipients is unclear. We report the case of a patient who had persistent invasive pulmonary aspergillosis despite prolonged treatment with amphotericin B. A combined approach using antifungal therapy and surgery appears effective for localized pulmonary disease. Aspergillar infection in solid organ transplant recipients is reviewed.
Original language | English (US) |
---|---|
Pages (from-to) | 698-700 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Oct 1992 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases